 |
|
 |
 |

Home > Company Index > Drugs > Biotechnology-Medicine > Inspire Pharmaceuticals, Inc.
 |
Inspire Pharmaceuticals, Inc. |
 |
 |
 |
PROFILE |
 |
Inspire Pharmaceuticals won't leave a dry eye in the house. The development-stage company develops drugs to treat various respiratory and ocular diseases caused by malfunctioning P2Y receptors, which regulate the body's mucosal hydration. Its lead drug candidates are in clinical trials to treat dry eye disease, chronic bronchitis, and cystic fibrosis. Other products in Inspire's pipeline target sinusitis, retinal diseases, and the diagnosis of lung diseases, including cancer. The firm's development partners include Genentech and Kissei Pharmaceuticals. Investors in Inspire include Domain Associates and InterWest Partners.
COMPETITION |
 |
Allergan, Inc. (AGN)
Bausch & Lomb Incorporated (BOL)
Schering-Plough Corporation (SGP)
|
 |
STOCK ANALYSIS |
 |
FURTHER ANALYSIS
Advanced Charting
Deals
FINANCIAL OVERVIEW |
 |
Fiscal Year-End: December
2000 Sales (mil.): 5.40
1-Yr. Sales Growth: 390.9%
Employees: 37
Revenue per employee: $145,945.95
KEY PEOPLE |
 |
Christy L. Shaffer
CEO
Roger A. Francis
CFO
CONTACT INFO |
 |
4222 Emperor Blvd., Ste. 470
Durham, NC 27703
US
Phone: 919-941-9777
Fax: 919-941-9797
Online: Web Site
|
 |
 |
 |
|
Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.
|

|
 |
 |
|
 |